Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinase.

Mendoza RA, Moody EE, Enriquez MI, Mejia SM, Thordarson G.

J Endocrinol. 2011 Jan;208(1):11-9. doi: 10.1677/JOE-10-0237. Epub 2010 Oct 25.

PMID:
20974639
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.

Mendoza RA, Enriquez MI, Mejia SM, Moody EE, Thordarson G.

J Endocrinol. 2011 Jan;208(1):1-9. doi: 10.1677/JOE-10-0235. Epub 2010 Oct 25.

PMID:
20974640
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Lipoxin A4 regulates expression of the estrogen receptor and inhibits 17β-estradiol induced p38 mitogen-activated protein kinase phosphorylation in human endometriotic stromal cells.

Chen S, Wu RF, Su L, Zhou WD, Zhu MB, Chen QH.

Fertil Steril. 2014 Jul;102(1):264-71. doi: 10.1016/j.fertnstert.2014.03.029. Epub 2014 May 16.

PMID:
24835059
[PubMed - indexed for MEDLINE]
4.

Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.

Takahashi M, Otsuka F, Miyoshi T, Otani H, Goto J, Yamashita M, Ogura T, Makino H, Doihara H.

J Endocrinol. 2008 Dec;199(3):445-55. doi: 10.1677/JOE-08-0226. Epub 2008 Sep 9.

PMID:
18780779
[PubMed - indexed for MEDLINE]
Free Article
5.

Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.

Han WD, Mu YM, Lu XC, Xu ZM, Li XJ, Yu L, Song HJ, Li M, Lu JM, Zhao YL, Pan CY.

Endocr Relat Cancer. 2003 Jun;10(2):217-24.

PMID:
12790785
[PubMed - indexed for MEDLINE]
Free Article
6.

Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.

Liu H, Pedram A, Kim JK.

Cardiovasc Res. 2011 Jan 1;89(1):119-28. doi: 10.1093/cvr/cvq265. Epub 2010 Aug 19.

PMID:
20724307
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.

Teng J, Wang ZY, Jarrard DF, Bjorling DE.

Endocr Relat Cancer. 2008 Mar;15(1):351-64. doi: 10.1677/erc.1.01255.

PMID:
18310301
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.

Zhang X, Mukerji R, Samadi AK, Cohen MS.

BMC Complement Altern Med. 2011 Oct 6;11:84. doi: 10.1186/1472-6882-11-84.

PMID:
21978374
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.

Antoon JW, Bratton MR, Guillot LM, Wadsworth S, Salvo VA, Burow ME.

Cancer Biol Ther. 2012 Sep;13(11):1026-33. doi: 10.4161/cbt.20992. Epub 2012 Jul 24.

PMID:
22825349
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.

Zheng F, Tang Q, Wu J, Zhao S, Liang Z, Li L, Wu W, Hann S.

J Exp Clin Cancer Res. 2014 Apr 26;33:36. doi: 10.1186/1756-9966-33-36.

PMID:
24766860
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.

Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L.

Cancer Prev Res (Phila). 2012 Jun;5(6):864-73. doi: 10.1158/1940-6207.CAPR-11-0575. Epub 2012 Apr 11.

PMID:
22496388
[PubMed - indexed for MEDLINE]
12.

The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.

Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q.

Biochim Biophys Acta. 2008 Jun;1783(6):1220-8. doi: 10.1016/j.bbamcr.2008.01.026. Epub 2008 Feb 12.

PMID:
18302941
[PubMed - indexed for MEDLINE]
Free Article
13.

Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells.

Behrens D, Gill JH, Fichtner I.

Mol Cell Endocrinol. 2007 Aug 15;274(1-2):19-29. Epub 2007 May 24.

PMID:
17597290
[PubMed - indexed for MEDLINE]
14.

Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK.

Zhu Y, Zhang T, Xie S, Tu R, Cao Y, Guo X, Zhou J, Zhou X, Cao L.

Biomed Pharmacother. 2012 Dec;66(8):569-77. doi: 10.1016/j.biopha.2012.02.003. Epub 2012 Mar 27.

PMID:
23102719
[PubMed - indexed for MEDLINE]
15.

Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.

Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC.

J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59.

PMID:
16333030
[PubMed - indexed for MEDLINE]
Free Article
16.

[The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].

Zhang YX, Kong CZ.

Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):271-5. Chinese.

PMID:
18361842
[PubMed - indexed for MEDLINE]
17.
18.

Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.

Chen FP, Chien MH, Chen HY, Huang TS, Ng YT.

Taiwan J Obstet Gynecol. 2013 Sep;52(3):365-73. doi: 10.1016/j.tjog.2012.09.038.

PMID:
24075375
[PubMed - indexed for MEDLINE]
19.

Estrous cycle modulates ovarian carcinoma growth.

Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM, Langley RR, Schmandt R, Lutgendorf SK, Cole SW, Sood AK.

Clin Cancer Res. 2009 May 1;15(9):2971-8. doi: 10.1158/1078-0432.CCR-08-2525. Epub 2009 Apr 21.

PMID:
19383821
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).

Chaudhri RA, Olivares-Navarrete R, Cuenca N, Hadadi A, Boyan BD, Schwartz Z.

J Biol Chem. 2012 Mar 2;287(10):7169-81. doi: 10.1074/jbc.M111.292946. Epub 2012 Jan 13.

PMID:
22247547
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk